Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Eisai has launched its insomnia drug Dayvigo in Japan, the second in a new class of medicines after Merck & Co’s Belsomra, which made its debut there in 2014.

Idorsia on course to take on Eisai and Merck & Co after late...

Switzerland’s Idorsia says it is on course to file a potential next-generation insomnia drug around the end of this year after a second batch of supportive phase 3 trial results, although t

Eisai and Alexa skills in epilepsy: the pharmaphorum podcast

Voice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world one of the companies working in this area is Eisai.

Pharma giants including Novartis collaborate on COVID-19 the...

A consortium of life sciences companies including pharma giants such as Novartis and Johnson & Johnson, are to collaborate to develop and manufacture vaccines, diagnostics and treatment

FDA clears Eisai’s insomnia drug Dayvigo

Surprise! Biogen says Alzheimer’s drug works after all and w...